Peripheral neuropathy decisions — 2025

The Board denied the Veteran's claims for an earlier effective date for the grant of service connection for bilateral lower extremity peripheral neuropathy of various nerves.

The Board remands the claims for service connection for diabetes mellitus, type II and neuropathy of both lower extremities due to a need for further development, including VA examinations.

The Board granted service connection for DMII and PN due to diabetes, but denied service connection for low back pain.

The Board granted increased ratings for the Veteran's left and right upper extremity peripheral neuropathy, effective December 31, 2015, but denied all other claims.

The Board granted service connection for bilateral lower extremity peripheral neuropathy on a direct basis, effective December 17, 2023.

The Board granted a 30 percent rating for the pelvic girdle muscles and denied ratings of more than 50 percent for the wound, fragment abdomen, right groin area, and any compensable ratings for femoral cutaneous nerve neuropathy or obturator neuropathy. The effective date for TDIU was also set to September 26, 2007.

The Board granted service connection for bilateral lower extremity peripheral neuropathy due to in-service toxic exposure.

The Board granted an initial 20 percent rating for right and left lower extremity peripheral neuropathy affecting the femoral nerve, effective February 4, 2011.

The Veteran withdrew the appeal for service connection for bilateral lower extremity peripheral neuropathy, and the Board dismissed the appeal.

The Board remands the Veteran's claims for service connection for peripheral neuropathy of both lower extremities due to a pre-decisional duty-to-assist error, specifically an inadequate VA medical opinion.

The Board denied service connection for high cholesterol, left hand disability (nerve damage, tendonitis and neuropathy), and right hand disability (nerve damage, tendonitis and neuropathy) due to lack of evidence supporting a current disability.

The Board granted the restoration of a 100 percent rating for prostate cancer effective April 1, 2022, and denied service connection for diabetes mellitus, type II. The claims for service connection for major depressive disorder and peripheral neuropathy of the bilateral lower extremities were remanded.

The Board remands the claims for service connection for left and right lower extremity peripheral neuropathy due to a pre-decisional duty to assist error.

The Board granted service connection for a heart disability, claimed as CAD and left lower extremity peripheral neuropathy (LLE PN) under the PACT Act. However, it remanded the claims for right lower extremity peripheral neuropathy (RLE PN), left upper extremity peripheral neuropathy (LUE PN), and right upper extremity peripheral neuropathy (RUE PN) due to pre-decisional error.

The Board granted service connection for tinnitus, finding that the Veteran's tinnitus had onset during active service and is related to in-service noise exposure. The other claims were remanded for further development.

The Board denied the veteran's claims for increased ratings and service connection, as well as a TDIU claim.

The Board denied service connection for chronic fatigue syndrome and right lower extremity diabetic peripheral neuropathy, as the evidence did not support a current disability or a link to service. The claim for obstructive sleep apnea was remanded for further development.

The Board remands the claims for service connection for bilateral lower extremity diabetic peripheral neuropathy to correct pre-decisional duty to assist errors.

The Board dismissed the veteran's appeal for service connection for heart disability, prostate cancer, diabetes mellitus, type II, and peripheral neuropathy due to a lack of jurisdiction.

The Board denied the Veteran's claims for increased ratings and service connection, finding that the evidence did not support higher ratings or service connection.